Aspirin as an Adjunctive Pharmacologic Therapy Option for COVID-19: Anti-Inflammatory, Antithrombotic, and Antiviral Effects All in One Agent

Autor: Tantry US, Schror K, Navarese EP, Jeong YH, Kubica J, Bliden KP, Gurbel PA

Publikováno v: Journal of Experimental Pharmacology, Vol Volume 13, Pp 957-970 (2021)

Udaya S Tantry,1 Karsten Schror,2 Eliano Pio Navarese,3 Young-Hoon Jeong,4 Jacek Kubica,3 Kevin P Bliden,1 Paul A Gurbel1 1Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, LifeBridge Health, Baltimore, MD, USA;

Externí odkaz: https://doaj.org/article/99f5810c84de4ba7928a5f1c1ed2612f

From proprotein convertase subtilisin/kexin type 9 to its inhibition: state-of-the-art and clinical implications

Autor: Navarese, EP, Kolodziejczak, M, Dimitroulis, D, Wolff, G, Busch, HL, Devito, F, Sionis, A, Ciccone, MM

Publikováno v: European Heart Journal-Cardiovascular Pharmacotherapy
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Statins are recommended as first-line therapy for patients with hypercholesterolaemia. A sizable proportion of patients, however, does not reach therapeutic goals, is statin intolerant, or, despite optimal statin therapy, is at high risk of ischaemic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::b1d6f76a8fdc0574bd9a337a535c31ce
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=14429

Drug-eluting stents vs. bare metal stents in saphenous vein graft disease. Insights from a meta-analysis of 7,090 patients

Autor: Lupi, A, Navarese, EP, Lazzero, M, Sansa, M, De Servi, S, Serra, A, Bongo, AS, Buffon, A

Publikováno v: CIRCULATION JOURNAL
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Background: Evidence supporting the use of drug-eluting stents (DES) in saphenous vein graft (SVG) disease is uncertain. Previous studies have suggested that DES might reduce the re-intervention rate in SVG disease, with conflicting data on mortality

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::556826799625dae7652b97e095f05f9f
http://hdl.handle.net/10807/57499

Treating acute coronary syndromes with new antiplatelet drugs: the mortality issue with prasugrel and ticagrelor.

Autor: De Servi S, Navarese EP, D'Urbano M, Savonitto S

Publikováno v: Current Medical Research & Opinion; 2011 Nov, Vol. 27 Issue 11, p2117-2122, 6p

Effect of α-lipoic acid on platelet reactivity in type 1 diabetic patients.

Autor: Mollo R, Zaccardi F, Scalone G, Scavone G, Rizzo P, Navarese EP, Manto A, Pitocco D, Lanza GA, Ghirlanda G, Crea F, Mollo, Roberto, Zaccardi, Francesco, Scalone, Giancarla, Scavone, Giuseppe, Rizzo, Paola, Navarese, Eliano Pio, Manto, Andrea, Pitocco, Dario, Lanza, Gaetano Antonio

Publikováno v: Diabetes Care; Feb2012, Vol. 35 Issue 2, p196-197, 2p